Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling with platelet-rich plasma can improve different types of hair loss.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Immunotherapy can help treat severe alopecia areata.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Oxidative stress is linked to mild patchy alopecia areata.

People with alopecia areata may have a higher risk of blood clots.

Both treatments for localized alopecia areata are equally effective.

Trichoscopy is crucial for diagnosing and assessing alopecia areata in children.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Higher RBP4 levels found in people with two types of hair loss.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

No systemic treatment for alopecia areata has strong evidence of effectiveness.